Cargando…

Correction: Establishment of a Murine Graft-versus-Myeloma Model Using Allogeneic Stem Cell Transplantation

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331534/ https://www.ncbi.nlm.nih.gov/pubmed/25689516 http://dx.doi.org/10.1371/journal.pone.0117643

Ejemplares similares

Establishment of a Murine Graft-versus-Myeloma Model Using Allogeneic Stem Cell Transplantation
por: Binsfeld, Marilène, et al.
Publicado: (2014)

Correction: Characteristics and risk of chronic graft-versus-host disease of liver in allogeneic hematopoietic stem cell transplant recipients
por: Chen, Chien-Ting, et al.
Publicado: (2018)

Author Correction: A convolutional neural network-based model that predicts acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
por: Jo, Tomoyasu, et al.
Publicado: (2023)

Allogeneic Stem Cell Transplantation in Multiple Myeloma
por: Greil, Christine, et al.
Publicado: (2021)

Correction: Ruxolitinib plus extracorporeal photopheresis (ECP) for steroid refractory acute graft-versus-host disease of lower GI-tract after allogeneic stem cell transplantation leads to increased regulatory T cell level
por: Modemann, Franziska, et al.
Publicado: (2021)

Acute Renal Graft-Versus-Host Disease in a Murine Model of Allogeneic Bone Marrow Transplantation
por: Schmid, Peter M., et al.
Publicado: (2017)

Correction to: No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease
por: Thiel, U., et al.
Publicado: (2021)

Correction: Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey
por: Sellner, Leopold, et al.
Publicado: (2021)

Correction: Astrovirus Infection in Hospitalized Infants with Severe Combined Immunodeficiency after Allogeneic Hematopoietic Stem Cell Transplantation
por: Wunderli, Werner, et al.
Publicado: (2012)

Correction to: Current Status and Perspectives of Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia
Publicado: (2022)

Current Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma
por: Claveau, Jean-Sébastien, et al.
Publicado: (2022)

Interleukin-22 in Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation
por: Lamarthée, Baptiste, et al.
Publicado: (2016)

Purinergic Signalling in Allogeneic Haematopoietic Stem Cell Transplantation and Graft-versus-Host Disease
por: Cuthbertson, Peter, et al.
Publicado: (2021)

Optimizing allogeneic grafts in hematopoietic stem cell transplantation
por: Xu, Zheng‐Li, et al.
Publicado: (2021)

Correction: Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation
por: Mohanan, E., et al.
Publicado: (2018)

Correction: Allogeneic hematopoietic stem cell transplantation for relapsed acute myeloid leukemia in ETO positive with reduced-intensity conditioning
por: Guo, Zhi, et al.
Publicado: (2019)

The Role of Pattern-Recognition Receptors in Graft-Versus-Host Disease and Graft-Versus-Leukemia after Allogeneic Stem Cell Transplantation
por: Heidegger, Simon, et al.
Publicado: (2014)

Correction: Earlier relapse detection after allogeneic haematopoietic stem cell transplantation by chimerism assays: Digital PCR versus quantitative real-time PCR of insertion/deletion polymorphisms
por: Valero-Garcia, Jennifer, et al.
Publicado: (2019)

Correction: Sequential Anti-Cytomegalovirus Response Monitoring May Allow Prediction of Cytomegalovirus Reactivation after Allogeneic Stem Cell Transplantation
por: Borchers, Sylvia, et al.
Publicado: (2013)

Correction: Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma
por: Yang, Luxin, et al.
Publicado: (2020)

Correction: Establishment of a Novel Murine Model of Ischemic Cardiomyopathy with Multiple Diffuse Coronary Lesions
por: Nakaoka, Hajime, et al.
Publicado: (2013)

Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
por: Nassar, Amr, et al.
Publicado: (2014)

Antibiotic Therapy and Gastrointestinal Graft-Versus-Host Disease in the Allogeneic Stem Cell Transplantation Population
por: Thomas, Jessica, et al.
Publicado: (2022)

Long-term outcomes of allogeneic stem cell transplant in multiple myeloma
por: Schmidt, Walker M., et al.
Publicado: (2023)

Correction to: Allogeneic hematopoietic stem cell transplantation in two brothers with DNA ligase IV deficiency: a case report and review of the literature
por: Schober, Sarah, et al.
Publicado: (2019)

Safe and effective use of outpatient non-myeloablative allogeneic stem cell transplantation for myeloma
por: Campbell, P, et al.
Publicado: (2014)

Correction to: Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia
por: Greil, C., et al.
Publicado: (2021)

Correction to: Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high‑dose melphalan and autologous stem cell transplantation
por: Martino, Massimo, et al.
Publicado: (2023)

Helper Innate Lymphoid Cells in Allogenic Hematopoietic Stem Cell Transplantation and Graft Versus Host Disease
por: Quatrini, Linda, et al.
Publicado: (2020)

Graft-versus-host disease in allogeneic transplantation: the good and the bad
por: Kröger, Nicolaus-Martin
Publicado: (2022)

Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease
por: van Lier, Yannouck F., et al.
Publicado: (2023)

Muscle Cramps and Neuropathies in Patients with Allogeneic Hematopoietic Stem Cell Transplantation and Graft-versus-Host Disease
por: Kraus, Peter D., et al.
Publicado: (2012)

Myasthenia Gravis Presenting as Graft versus Host Disease after Allogeneic Blood Stem Cell Transplant
por: Ahmed, Zarir, et al.
Publicado: (2018)

Demodicidosis Accompanying Acute Cutaneous Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation
por: Aytan, Pelin, et al.
Publicado: (2018)

Dermoscopy of Cutaneous Graft-Versus-Host-Disease in Patients After Allogeneic Hematopoietic Stem Cell Transplantation
por: Kaminska-Winciorek, Grażyna, et al.
Publicado: (2020)

Publisher Correction: Syngeneic Mesenchymal Stem Cells Reduce Immune Rejection After Induced Pluripotent Stem Cell-Derived Allogeneic Cardiomyocyte Transplantation
por: Yoshida, Shohei, et al.
Publicado: (2020)

Correction to: mRNA-1273 SARS-CoV-2 vaccine safety and COVID-19 risk perception in recently transplanted allogeneic hematopoietic stem cell transplant recipients
por: Albiol, Nil, et al.
Publicado: (2022)

Long-term outcome after allogeneic stem cell transplantation in multiple myeloma
por: Luoma, Sini, et al.
Publicado: (2021)

Correction: Interleukin 21 Signaling in B Cells Is Required for Efficient Establishment of Murine Gammaherpesvirus Latency
Publicado: (2015)

Effect of acute and chronic graft-versus-host disease on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myeloma
por: Ringdén, Olle, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_65r8e7fki3jv0nrb2p667so09c